NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.


Player Avatar aerialist (28.74) Submitted: 2/25/2013 7:47:23 PM : Outperform Start Price: $7.55 NPSP Score: +311.12

A major drug for short bowel syndrome. Although there are only about 15,000 patients in the US with this affliction-revenue production will be significant enough to warrant a takeover bid by a major pharma.

Featured Broker Partners